The AJMC® Infectious Disease compendium is a comprehensive resource for news and interviews about the viruses, bacteria, fungi, and parasites that create illness and outbreaks.
February 7th 2024
Results show that wastewater surveillance was sufficiently sensitive to detect Monkeypox virus (mpox) cases in these large, pooled samples.
Starting July 1, credit-reporting giants will remove certain medical debts; AstraZeneca’s Evusheld was shown to reduce the viral load of subvariants BA.1, BA1.1, and BA.2; about 4% of middle school students and 13% of high school students use some type of tobacco product, according to a report.
Read More
Study Finds C difficile Infection Manageable in Primary Care Settings With Specialist Guidance
March 17th 2022Cases of Clostridioides difficile (C diff) have increasingly been reported outside of typical settings, and a survey of general practitioners in France found that many cases can be managed without hospitalization.
Read More
Looking Beyond COVID-19, US Health Officials Outline Next Steps to Fight Disease
March 2nd 2022From one-stop testing and treatment sites to boosting research and surveillance, Biden administration health officials expanded on the COVID-19 plan the president announced in his State of the Union address Tuesday night, but the plan will require additional funding from Congress.
Read More
Dr Peter Hotez on Combatting Antivaccination Beliefs and Rescuing Public Health From Politics
December 21st 2021In an interview conducted before the highly transmissible Omicron coronavirus variant began driving another wave of infections, Peter Hotez, MD, PhD, FASTMH, discussed the struggle public health officials and scientists have in fighting false beliefs about vaccinations.
Watch
Community Oncology Leaders Find Silver Linings in the Pandemic
December 20th 2021Debra Patt, MD, PhD, MBA, of Texas Oncology, and Lucio Gordan, MD, of Florida Cancer Specialists, MD, presented data from a study they conducted in partnership with the Community Oncology Alliance and Avalere Health.
Read More
Dr Leslie Kantor: Mild Flu Seasons Make Future Vaccine Matching Tricky
December 18th 2021When a flu season is mild, it can make developing a vaccine for the following season a bit more difficult as it can be hard to find the right match, but on the other hand, the US health system could benefit from less stress this winter given the unrelenting demands posed by COVID-19, says Leslie Kantor, PhD, MPH, chair and professor of the Department of Urban-Global Public Health, Rutgers School of Public Health.
Watch
Payer Perspectives on Coverage Criteria for Clostridium Difficile Treatments
Payer participants break down how coverage criteria are determined for treatments for clostridium difficile infection.
Watch
Treatment Guidelines and Recommendations for C. Diff Infection
Shared insight on the differences between ACG and IDSA/SHEA treatment guidelines for patients with clostridium difficile infection.
Watch
GAO Report: Policies to Incentivize Vaccine Development and Investment
November 24th 2021The report briefly explained the policy options that policymakers can use to help address challenges related to vaccine research and development, testing, and manufacturing, as well as the economic challenges related to vaccine development for infectious diseases.
Read More
Identifying Treatment Goals for Recurrent CDI
A panel of experts review treatment goals and assessing response in patients with recurrent clostridium difficile infection.
Watch
Impact of Recurrent CDI on Patients and the Healthcare System
A broad view on the impact of recurrent clostridium difficile infection on patients and the healthcare system at large.
Watch
Infection Prevention Practices, Frontline Education Led to Decrease in C difficile Infections
November 22nd 2021A multifaceted approach focused on enforcing basic infection prevention practices and promoting education about Clostridioides difficile (C difficile) transmission led to a reduction in the number of infections in a hospital setting.
Read More
Recurrent CDI: Risk Factors and Outcomes
Experts focus on recurrent clostridium difficile infection to define risk factors and discuss impact on patient outcomes.
Watch
Defining Traditional Risk Factors for Developing C. Diff Infection
Opening their discussion, panelists elucidate patient factors that may impact risk of developing clostridium difficile infection.
Watch
Dr Leslie Kantor on Communicating Importance of Receiving Both Flu, COVID-19 Vaccines
November 12th 2021Leslie Kantor, PhD, MPH, chair and professor of the Department of Urban-Global Public Health, Rutgers School of Public Health, discusses the key messages that people need to hear about the continued importance of the flu vaccine, even if they have been immunized for COVID-19.
Watch
What We’re Reading: Measles Outbreaks Possible; NIH vs Moderna; Mental Health Benefits Expand
November 11th 2021The World Health Organization and CDC warn of the potential for measles outbreaks; the National Institutes of Health (NIH) and Moderna battle over patent rights to Moderna’s COVID-19 vaccine; a new Kaiser Family Foundation shows employers have increased mental health care offerings.
Read More
The CDC director endorsed a pediatric Pfizer COVID-19 vaccine for children aged 5 to 11 years; proposed drug pricing reform will allow Medicare Part D to negotiate directly with pharmaceutical companies; some employers may not send death benefits to families of employees who die of COVID-19 without being vaccinated.
Read More
Dr Peter Hotez on the Urgent Need for a COVID-19 Vaccine for Children
October 30th 2021Peter Hotez, MD, PhD, FASTMH, professor of pediatrics and molecular virology and dean, National School of Tropical Medicine, Baylor College of Medicine, and codirector, Texas Children’s Hospital Center for Vaccine Development, addresses the approval of the Pfizer/BioNTech COVID-19 vaccine for children aged 5 to 11 and emphasized its benefits far outweigh the rare possibility of myocarditis.
Watch
Study Identifies Possible Molecular Target for Clostridioides difficile Infection Therapies
October 23rd 2021A study funded by the National Institutes of Health found that Glucosyltransferase domain is a possible molecular target for therapeutic interventions for Clostridioides difficile infection.
Read More